
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Discovery of a novel potent tubulin inhibitor through virtual screening and target validation for cancer chemotherapy - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4B3D98AF38B9305B3D90042CDF3AF.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cddiscover">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365163/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cell Death Discovery">
<meta name="citation_title" content="Discovery of a novel potent tubulin inhibitor through virtual screening and target validation for cancer chemotherapy">
<meta name="citation_author" content="Peipei Shan">
<meta name="citation_author_institution" content="Institute of Translational Medicine, the Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, China">
<meta name="citation_author" content="Kai-Lu Liu">
<meta name="citation_author_institution" content="School of Biological Science and Technology, University of Jinan, Jinan, China">
<meta name="citation_author" content="Xiu Jiang">
<meta name="citation_author_institution" content="Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, China">
<meta name="citation_author" content="Guangzhao Zhou">
<meta name="citation_author_institution" content="Department of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, China">
<meta name="citation_author" content="Kongkai Zhu">
<meta name="citation_author_institution" content="School of Biological Science and Technology, University of Jinan, Jinan, China">
<meta name="citation_author_institution" content="Advanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Jinan, China">
<meta name="citation_author" content="Hua Zhang">
<meta name="citation_author_institution" content="Institute of Translational Medicine, the Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, China">
<meta name="citation_author_institution" content="School of Biological Science and Technology, University of Jinan, Jinan, China">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="11">
<meta name="citation_firstpage" content="392">
<meta name="citation_doi" content="10.1038/s41420-025-02679-3">
<meta name="citation_pmid" content="40830098">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365163/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365163/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365163/pdf/41420_2025_Article_2679.pdf">
<meta name="description" content="Microtubules, critical to diverse cellular processes, represent a clinically validated target for anticancer therapeutics. In this study, a virtual screening of the Specs library, consisting of 200,340 compounds, was conducted to target the taxane ...">
<meta name="og:title" content="Discovery of a novel potent tubulin inhibitor through virtual screening and target validation for cancer chemotherapy">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Microtubules, critical to diverse cellular processes, represent a clinically validated target for anticancer therapeutics. In this study, a virtual screening of the Specs library, consisting of 200,340 compounds, was conducted to target the taxane ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365163/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12365163">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41420-025-02679-3"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41420_2025_Article_2679.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12365163%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12365163/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12365163/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365163/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cddiscover.jpg" alt="Cell Death Discovery logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cell Death Discovery" title="Link to Cell Death Discovery" shape="default" href="http://www.nature.com/cddiscovery/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cell Death Discov</button></div>. 2025 Aug 19;11:392. doi: <a href="https://doi.org/10.1038/s41420-025-02679-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41420-025-02679-3</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Cell%20Death%20Discov%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cell%20Death%20Discov%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cell%20Death%20Discov%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cell%20Death%20Discov%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Discovery of a novel potent tubulin inhibitor through virtual screening and target validation for cancer chemotherapy</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shan%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Peipei Shan</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Peipei Shan</span></h3>
<div class="p">
<sup>1</sup>Institute of Translational Medicine, the Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shan%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Peipei Shan</span></a>
</div>
</div>
<sup>1,</sup><sup>✉,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20KL%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Kai-Lu Liu</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Kai-Lu Liu</span></h3>
<div class="p">
<sup>2</sup>School of Biological Science and Technology, University of Jinan, Jinan, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20KL%22%5BAuthor%5D" class="usa-link"><span class="name western">Kai-Lu Liu</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Xiu Jiang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Xiu Jiang</span></h3>
<div class="p">
<sup>3</sup>Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiu Jiang</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Guangzhao Zhou</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Guangzhao Zhou</span></h3>
<div class="p">
<sup>4</sup>Department of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Guangzhao Zhou</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Kongkai Zhu</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Kongkai Zhu</span></h3>
<div class="p">
<sup>2</sup>School of Biological Science and Technology, University of Jinan, Jinan, China </div>
<div class="p">
<sup>5</sup>Advanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Jinan, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kongkai Zhu</span></a>
</div>
</div>
<sup>2,</sup><sup>5,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Hua Zhang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Hua Zhang</span></h3>
<div class="p">
<sup>1</sup>Institute of Translational Medicine, the Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, China </div>
<div class="p">
<sup>2</sup>School of Biological Science and Technology, University of Jinan, Jinan, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hua Zhang</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Institute of Translational Medicine, the Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, China </div>
<div id="Aff2">
<sup>2</sup>School of Biological Science and Technology, University of Jinan, Jinan, China </div>
<div id="Aff3">
<sup>3</sup>Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, China </div>
<div id="Aff4">
<sup>4</sup>Department of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, China </div>
<div id="Aff5">
<sup>5</sup>Advanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Jinan, China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 7; Revised 2025 Jul 9; Accepted 2025 Aug 4; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12365163  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40830098/" class="usa-link">40830098</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Microtubules, critical to diverse cellular processes, represent a clinically validated target for anticancer therapeutics. In this study, a virtual screening of the Specs library, consisting of 200,340 compounds, was conducted to target the taxane and colchicine binding sites on tubulin, resulting in the identification of 93 promising candidates for further analysis. Subsequent characterization revealed a nicotinic acid derivative (compound <strong>89</strong>) as a potent tubulin inhibitor, demonstrating significant anti-tumor efficacy in vitro and in vivo, with no observable toxicity at therapeutic doses in mice. Notably, compound <strong>89</strong> also exhibited robust antitumor activity in patient-derived organoids. Mechanistic studies, including EBI competitive binding assays and molecular docking, confirmed its inhibition toward tubulin polymerization via selective binding to the colchicine site. Furthermore, compound <strong>89</strong> disrupted tubulin assembly dynamics through modulation of the PI3K/Akt signaling pathway. This work presents a novel tubulin-inhibiting scaffold with potential for advancing next-generation microtubule-targeted chemotherapies.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Subject terms:</strong> Cancer prevention, Virtual screening, Chemotherapy, Drug development</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">Microtubules play crucial roles in many cellular events, comprising formation of spindles, intracellular signaling transduction and substance transportation, as well as regulation of cell motility, division and apoptosis [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>–<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Its polymeric structures compose of the heterodimers of α and β-tubulin, which is a highly dynamic process characterized by the rapid cycles of polymerization/depolymerization through the addition or removal of tubulin dimers [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. The dynamics of microtubule assembly is precisely modulated to mediate the aforementioned cellular events, and any disturbance or interference on this process would lead to G<sub>2</sub>/M phase arrest of cells, eventually causing cell death [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>–<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Hence, the exploration of microtubule-targeting agents (MTAs) to perturb the dynamic stability of microtubule assembly represents an important strategy in antitumor therapy [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>–<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>].</p>
<p id="Par3">Given their important roles in regulating cellular processes, microtubules had been recognized as an ideal target for the development of antitumor medications since half century ago [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. Based on the different modes of action in modulating microtubule dynamics, MTAs can be primarily classified into microtubule-stabilizing agents and microtubule-destabilizing agents: the former enhance tubulin polymerization, while the latter inhibit tubulin polymerization [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. During the last several decades, numerous chemical compounds have been identified as promising MTAs with potent antitumor effects [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. At present, some MTAs such as taxol (paclitaxel), vinblastine and vincristine are still applied to clinical treatment especially for advanced cancers [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. Despite the great success of MTAs in anticancer drug research, there are still many challenges, including side effects and drug resistance, yet to be solved [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Thus, continuing efforts in the discovery and development of more MTAs with new chemical scaffolds, improved activities and reduced side effects are still of high demand.</p>
<p id="Par4">Colchicine-site tubulin inhibitors are well-known molecules that bind to an interface region of the α and β-tubulin subunits [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. Recently, inhibitors targeting the colchicine site have received tremendous attention due to their superior therapeutic potential (compared with other binding-site inhibitors), such as good water solubility, enhanced ability to inhibit angiogenesis and overcome multidrug resistance, and lower side effects [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. Several molecules binding to the colchicine-site are currently in clinical trials, including CA-4P, ABT-751, OXi4503, VERU-111 and BNC105P [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>–<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>], but none of them have been approved for clinical use. Hence, more endeavors are still required to uncover new chemical frameworks in order to address the current limitations.</p>
<p id="Par5">In a recent work, we described the identification of a novel type of natural inhibitor of tubulin from <em>Morinda officinalis</em> [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. As a continuation of the previous efforts for novel small molecules targeting microtubule, we lately carried out a virtual screening on the commercial Specs library containing &gt;200 thousand compounds, which was reworded with the discovery of two hit molecules <strong>82</strong> and <strong>89</strong> showing significant cytostatic activity against human Hela (cervical) and HCT116 (colonic) tumor cells. Subsequent antineoplastic evaluation and mechanistical exploration on the more active <strong>89</strong> identified it as a potent colchicine-site inhibitor that promoted the polymerization of tubulin. Compound <strong>89</strong> could interfere with the assembly of microtubules by inhibiting PI3K/Akt signaling pathway, exerted good in vitro and in vivo antitumor effects, and more excitingly inhibited the growth of patient-derived organoids. Hence, details of the aforementioned investigations will be described below.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Identification of 89 as a potential tubulin inhibitor with antiproliferative activity</h3>
<p id="Par6">MTAs are usually categorized into two main groups, namely, microtubule-stabilizing agents and microtubule-destabilizing agents [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. Among the seven known binding sites so far [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>], the classical taxane site and colchicine site, representative for the aforementioned two groups of MTAs, respectively, were chosen for the virtual screening in the current work, and the whole process was shown in Fig. <a href="#Fig1" class="usa-link">1A</a>. The commercially available Specs library with 200,340 synthetic molecules (<a href="https://www.specs.net/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.specs.net/</a>) was applied to the molecular docking using Glide 5.5 program [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. Top 300 structures for each binding site were first selected according to their docking scores, and a total of 420 compounds were obtained after the removal of duplicate molecules. Finally, 93 candidates were picked out for further study based on clustering analysis and visual inspection.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1. Virtual screening for MTAs identified compound 89 as a new potential anti-tumor small molecule.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365163_41420_2025_2679_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b55a/12365163/ea7a734d365f/41420_2025_2679_Fig1_HTML.jpg" loading="lazy" id="d33e389" height="999" width="765" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> High-throughput virtual screening workflow for new tubulin inhibitors. <strong>B</strong> HeLa and HCT116 cells were treated with the indicated compounds, and MTS assay was performed after 24 h. <strong>C</strong> The chemical structures of compounds <strong>82</strong> and <strong>89</strong>, and their IC<sub>50</sub> values against HeLa and HCT116 cells.</p></figcaption></figure><p id="Par7">The 93 compounds identified in the aforementioned computational screening were then purchased (the original Specs codes of these molecules that can be used to check their structures were provided in Supplementary Table <a href="#MOESM1" class="usa-link">S1</a>), and their antiproliferative activities against human Hela (cervical) and HCT116 (colonic) tumor cell lines were then tested at 50 μM. As shown in Fig. <a href="#Fig1" class="usa-link">1B</a>, compounds <strong>82</strong> and <strong>89</strong> (Fig. <a href="#Fig1" class="usa-link">1C</a>) displayed significant growth inhibition toward both cells (&gt;90% inhibitory rate), while other compounds only showed weak or no cytostatic effect (mostly &lt;50% inhibitory rate). The IC<sub>50</sub> values of <strong>82</strong> and <strong>89</strong> were further acquired, revealing a better activity for <strong>89</strong> than <strong>82</strong> against both cell lines (Fig. <a href="#Fig1" class="usa-link">1C</a>).</p>
<p id="Par8">To check if there are superior molecules in the Specs library, a retrieval for structural analogs of <strong>89</strong> was conducted, and 17 additional compounds were picked out, purchased and tested for their antiproliferative effect toward the aforementioned two cell lines (Supplementary Table <a href="#MOESM1" class="usa-link">S2</a>). The structure-activity relationship of all the tested molecules was then briefly discussed below. Compared with <strong>89</strong>, replacement of the phenyl unit by a hydroxyethyl group in <strong>A2</strong> caused the loss of inhibitory activity, while reduction of the carbonyl group to a methylene in <strong>A5</strong> also resulted in a decline in activity. Interestingly, a growth promoting effect was observed when the phenylpiperazine moiety was replaced by a piperidine unit in <strong>A3</strong>, whereas both the growth promoting and inhibitory effect disappeared upon further substitution of this piperidine unit by a morpholine fragment in <strong>A4</strong>. It was surprising to find that the cytostatic activity partially recovered by replacing the 2-piperidinyl group (of the pyridine ring) in <strong>A4</strong> with a hydroxyethylpiperazinyl unit in <strong>A6</strong>. Nevertheless, compounds <strong>A1</strong> and <strong>A7</strong> with piperidine and pyrrolidine moieties replacing the morpholine unit in <strong>A6</strong>, respectively, did not show obvious inhibition against both cell lines. In addition to the above-mentioned molecules, only compound <strong>B3</strong> with 2-isopropylpiperazinyl-5-pyrrolidinylcarbonyl substitution on the pyridine ring, among others bearing more structural variations, displayed moderate antiproliferative activity. Therefore, compound <strong>89</strong> appeared to be a potential lead compound as tubulin inhibitor and was thus chosen for the subsequent antitumor evaluation and mechanistical investigations.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Compound <strong>89</strong> inhibited the proliferation, invasion and migration of tumor cells</h3>
<p id="Par9">The antiproliferative effect of <strong>89</strong> was further evaluated in Hela, HCT116 and 4T1 cells by MTS assay. As can be seen in Fig. <a href="#Fig2" class="usa-link">2A</a>, <strong>89</strong> significantly reduced the viability of the three cancer cells in a dose-dependent manner. In addition, <strong>89</strong> also showed antitumor activity on other tumor cell lines of different origin (A549, H1299, MDA-MB231), indicating that <strong>89</strong> could be a broad-spectrum antitumor agent like other tubulin inhibitors (Supplementary Fig. <a href="#MOESM1" class="usa-link">S1</a>). Moreover, immunoblotting assay revealed a substantial downregulation of the PCNA protein (proliferating cell nuclear antigen) following treatment with <strong>89</strong> (Fig. <a href="#Fig2" class="usa-link">2B</a>). Colonial formation effectively mimics the in vivo pathological process of tumor progression, so the clonogenic ability of the three cell lines was then analyzed after treatment with <strong>89</strong>. As shown in Fig. <a href="#Fig2" class="usa-link">2C</a>, <strong>89</strong> markedly suppressed the colony formation of tumor cells in a dose-relying mode.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2. Compound 89 inhibited the proliferation, invasion and migration of tumor cells.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365163_41420_2025_2679_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b55a/12365163/649ce5a9b8a9/41420_2025_2679_Fig2_HTML.jpg" loading="lazy" id="d33e562" height="1000" width="752" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> HeLa, HCT116 and 4T1 cells were treated with increasing concentrations of <strong>89</strong>, and MTS assay was performed after 24 h. The bars indicate mean ± SD (<em>n</em> = 3). <strong>B</strong> HeLa, HCT116 and 4T1 cells were treated with indicated concentrations of <strong>89</strong>, and the expression of PCNA was detected by Western blot assay. Actin was used as loading control. <strong>C</strong> HeLa, HCT116 and 4T1 cells were seeded in 6-well plates, and after 12 h, cells were treated with indicated concentrations of <strong>89</strong>. On day 10, the number of colonies was counted in experiments repeated three times. Results represent the average of three replications. <strong>D</strong> HeLa, HCT116 and 4T1 cells were seeded in 6-well plates. A “wound” was created after the cells grew into full confluence, and different concentrations of <strong>89</strong> were added. Images were taken after 12 h of incubation at 37 °C. <strong>E</strong> HeLa, HCT116 and 4T1 cells were re-suspended in serum-free medium and seeded into the upper side of the transwell insert pre-coated with Matrigel. Increasing concentrations of <strong>89</strong> were added to both chambers, and images were obtained after 12 h of incubation. Bars represent mean ± SD of three independent experiments. <strong>F</strong> HeLa, HCT116 and 4T1 cells were treated with indicated concentrations of <strong>89</strong>, and the expression of EMT-related proteins was detected by Western blot assay with indicated antibodies. Bars represent mean ± SD from three independent experiments.</p></figcaption></figure><p id="Par10">Next, the anti-migratory and anti-invasive effects of <strong>89</strong> toward the three cell lines were then evaluated. The data shown in Fig. <a href="#Fig2" class="usa-link">2D</a> clearly indicated that the wound closure of the three cell lines was all markedly blocked by co-incubation with <strong>89</strong> in the wound healing experiment. Meanwhile, representative pictures and cell counts in Fig. <a href="#Fig2" class="usa-link">2E</a> demonstrated that the invasion of tumor cells was remarkably prevented by treatment of <strong>89</strong> in the Transwell assay. EMT (Epithelial-mesenchymal transition) is regarded as a crucial mechanism governing the early stages of tumor metastasis [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>], and the protein levels of relevant biomarkers were subsequently checked after administration of <strong>89</strong>. The data of Fig. <a href="#Fig2" class="usa-link">2F</a> illustrated that <strong>89</strong> could significantly increase the expression of E-cadherin (epithelial indicator) while decrease that of ZEB1 (zinc-finger E-box binding homeobox 1) and vimentin (mesenchymal markers). Together, these findings collectively suggest that <strong>89</strong> exhibits strong inhibitory effects on tumor metastasis in vitro.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Compound 89 induced cycle arrest and apoptosis in tumor cells</h3>
<p id="Par11">Cell cycle arrest and apoptosis are the primary mechanisms through which most anticancer drugs eliminate tumor cells. Flow cytometric experiment was then performed to investigate whether <strong>89</strong> could induce cell cycle arrest and apoptosis in tumor cells. Hela and HCT116 cells after exposure to <strong>89</strong> were first examined for their cycle distributions, and as illustrated in Fig. <a href="#Fig3" class="usa-link">3A</a>, treatment of <strong>89</strong> caused a significant G<sub>2</sub>/M phase arrest in both cell lines. <strong>89</strong> also induced G<sub>2</sub>/M phase arrest in 4T1 cell lines (Supplementary Fig. <a href="#MOESM1" class="usa-link">S2</a>). Subsequently, an immunoblotting assay was conducted to evaluate the impact of <strong>89</strong> on the expression of CDK1, Cyclin B1 and Cdc25c (G<sub>2</sub>/M phase related proteins). The results in Fig. <a href="#Fig3" class="usa-link">3B</a> showed that <strong>89</strong> upregulated the expression of cyclin B1 while downregulated those of CDK1 and Cdc25c. In addition, the effect of <strong>89</strong> on the morphology of HeLa cells was further examined through Hoechst 33342 staining (Fig. <a href="#Fig3" class="usa-link">3C</a>), which clearly revealed an accumulation of M-phase cells.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3. Compound 89 induced cycle arrest and apoptosis in tumor cells.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365163_41420_2025_2679_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b55a/12365163/682f7c01e2e6/41420_2025_2679_Fig3_HTML.jpg" loading="lazy" id="d33e679" height="997" width="712" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> HeLa and HCT116 cells were treated with indicated concentrations of <strong>89</strong> and co-incubated for 24 h. Cell population distribution was determined following PI staining and further analyzed by flow cytometry. Bars represent mean ± SD of three independent experiments. <strong>B</strong> HeLa, HCT116 and 4T1 cells were treated with indicated concentrations of <strong>89</strong> and the expression of cell cycle-related proteins was detected by Western immunoblotting assay with the indicated antibodies. <strong>C</strong> HeLa cells were treated with <strong>89</strong> at the indicated doses. Nuclei were stained with DAPI (blue) by immunofluorescence staining. Scale bar, 20 μm. <strong>D</strong> HeLa, HCT116 and 4T1 cells were left untreated or treated with <strong>89</strong> at the indicated doses for 24 h. Apoptotic cells were labeled with annexin V and PI and analyzed by flow cytometry. Bars represent mean ± SD of three independent experiments. <strong>E</strong> HeLa, HCT116 and 4T1 cells were treated with indicated concentrations of <strong>89</strong> and the expression of cleaved-PARP, Bax and Bcl-2 were detected by Western immunoblotting assay with the indicated antibodies. Protein expressions were quantitated by densitometry and normalized against that of actin. Bars represent mean ± SD of three independent experiments.</p></figcaption></figure><p id="Par12">Next, Annexin V-FITC/PI analysis demonstrated that <strong>89</strong> remarkably boosted the proportion of apoptotic cells in all three tested cell lines (Fig. <a href="#Fig3" class="usa-link">3D</a>). Afterwards, immunoblotting assay demonstrated that the expression of Cl. PARP (cleaved PARP), which is a biomarker of apoptosis, gradually enhanced with the treatment of escalating doses of <strong>89</strong> (Fig. <a href="#Fig3" class="usa-link">3E</a>), while those of Bax and Bcl-2 as pro-apoptosis and anti-apoptosis cytokines were up and down regulated, respectively.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Compound 89 served as a tubulin polymerization inhibitor of the colchicine site</h3>
<p id="Par13">To validate whether compound <strong>89</strong> directly targeted microtubule, CETSA (cellular thermal shift assay) was performed. The protein level of β-tubulin in the DMSO-treated group (as a control) (Fig. <a href="#Fig4" class="usa-link">4A</a>) declined in pace with the rising temperatures, indicating a protein degradation, while that in the <strong>89</strong>-treated group remained relative stable, which suggested the direct binding of <strong>89</strong> to β-tubulin.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4. Compound 89 was identified as a potent tubulin polymerization inhibitor binding to the colchicine site.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365163_41420_2025_2679_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b55a/12365163/54c4d3313015/41420_2025_2679_Fig4_HTML.jpg" loading="lazy" id="d33e753" height="1000" width="732" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> HeLa cells were lysed using liquid nitrogen and three repeated cycles of freeze-thaw, and the cell lysate was treated with <strong>89</strong> (10 μM) or DMSO for 30 min at r.t. The cell suspension was heated for 3 min to 40, 44, 48, 52, 56 and 60 °C, cooled at 25 °C for 3 min, and then centrifuged at 20,000 × <em>g</em> for 30 min. Finally, the supernatant was collected for Western blot analysis. <strong>B</strong> In vitro tubulin polymerization assay was performed. β-tubulin was exposed to DMSO, colchicine (10 µM), paclitaxel (10 µM) or the indicated concentrations of <strong>89</strong>. GTP was added to initiate the reaction. The tubulin polymerization rate was monitored for 60 min at 37 °C and the absorbance at 340 nm was measured. <strong>C</strong> Six-well plates were seeded with HeLa or HCT116 cells (2 × 10<sup>5</sup>) for 24 h. The tumor cells were incubated with <strong>89</strong>, colchicine or DMSO for 2 h and afterward treated with EBI (100 μM) for 1.5 h. Cells were finally harvested and lysed, and the cell extracts were used for Western blotting analysis. <strong>D</strong> Cut-away view of the ligand-binding pocket at the colchicine site in the docking complex of <strong>89</strong> with tubulin. <strong>E</strong> Diagrammatic illustration of the interactions between tubulin protein and <strong>89</strong>.</p></figcaption></figure><p id="Par14">To further check which type of MTA <strong>89</strong> is (stabilizing or destabilizing agent), the tubulin polymerization experiment was conducted, using colchicine (destabilizer) and paclitaxel (stabilizer) as reference compounds. The curves in Fig. <a href="#Fig4" class="usa-link">4B</a> indicated that paclitaxel rapidly promoted the polymerization of tubulin as anticipated, while in the presence of colchicine the tubulin assembly was severely impeded. Moreover, compound <strong>89</strong> exerted a similar effect to colchicine, disrupting the tubulin polymerization in a concentration-relying mode. These observations indicated that <strong>89</strong> functioned as a tubulin polymerization inhibitor (or microtubule destabilizer).</p>
<p id="Par15">Since compound <strong>89</strong> was screened out based on taxane and colchicine sites and the aforementioned assay confirmed its inhibitory effect on the polymerization of tubulin, it was thus assumed to be a colchicine-site inhibitor. Then, the EBI (<em>N</em>,<em>N</em>′-ethylenebis) competition assay was performed to verify this hypothesis. As shown in Fig. <a href="#Fig4" class="usa-link">4C</a>, only β-tubulin was detected in the blank and positive control groups, and both β-tubulin and EBI/β-tubulin adducts were detected in co-treatment groups of EBI and <strong>89</strong>. As the concentration of <strong>89</strong> rose, the band intensity of β-tubulin increased, whereas that of EBI/β-tubulin adduct decreased. These results indicated that <strong>89</strong> and EBI competed for the colchicine site.</p>
<p id="Par16">Lastly, molecular docking analysis was conducted to probe the interaction details of <strong>89</strong> with tubulin. Figure <a href="#Fig4" class="usa-link">4D</a> visualized that <strong>89</strong> could fully occupy the colchicine site with high affinity (docking score: −8.682), and it formed broad hydrophobic interactions with 16 amino acid residues (Fig. <a href="#Fig4" class="usa-link">4E</a>). In addition, three charged (one negative and two positive) and six polar interactions were also resolved. The docking results and detailed interactions of <strong>89</strong> with tubulin were provided in Fig. <a href="#Fig4" class="usa-link">4D, E</a> and Supplementary Table <a href="#MOESM1" class="usa-link">S3</a>.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Compound 89 suppressed tumor cell proliferation via disrupting microtubular network and organization</h3>
<p id="Par17">As microtubules represent one of the major components of eukaryotic cytoskeleton, the dynamic balance of its assembly from α and β-tubulin is very important to maintain cell morphology and survival. Immunofluorescence staining experiment was then employed to inspect the effect of <strong>89</strong> on the microtubular network in living cells. The photographs in Fig. <a href="#Fig5" class="usa-link">5A, B</a> clearly demonstrated that in the blank control groups, the microtubules were well-organized and spanned the entire cell to support the structure and shape of cells. In contrast, treatment with <strong>89</strong> resulted in disorganized microtubular networks and cellular shrinkage. Furthermore, immunoblotting experiment was conducted to assess the effect of <strong>89</strong> on α and β-tubulins, and the results in Fig. <a href="#Fig5" class="usa-link">5C</a> revealed that the expressions of both proteins were notably downregulated upon treatment of <strong>89</strong>. Moreover, colony formation assay in soft agar was further conducted, and it was demonstrated by the experimental pictures (Fig. <a href="#Fig5" class="usa-link">5D</a>) that the proliferation of tumor cells was significantly blocked by administration with <strong>89</strong>. Collectively, these results corroborated that <strong>89</strong> inhibited tumor cell proliferation by disrupting the network and organization of microtubules.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5. Compound 89 suppressed tumor cell proliferation via disrupting microtubule network and organization.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365163_41420_2025_2679_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b55a/12365163/58bd030e3da0/41420_2025_2679_Fig5_HTML.jpg" loading="lazy" id="d33e889" height="1000" width="783" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>, <strong>B</strong> HeLa cells were treated with increasing concentrations of <strong>89</strong> for 24 h. Tubulin was stained with anti-α-tubulin (green) and anti-β-tubulin (red) antibodies, while the nucleus (blue) was stained with DAPI. The boxed areas were magnified to show clearer changes of the microtubule network in <strong>89</strong>-treated cells by immunofluorescence assay. <strong>C</strong> HeLa, HCT116 and 4T1 cells were treated with indicated concentrations of <strong>89</strong> and the expressions of α and β-tubulin were detected by Western immunoblotting assay with the indicated antibodies. Protein expressions were quantitated by densitometry and normalized against that of actin. <strong>D</strong> HCT116 cells were treated with increasing concentrations of <strong>89</strong>, and then soft agar colony formation assay was performed. Bars represent mean ± SD of three independent experiments. ns, no significant difference, *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001 versus the control group.</p></figcaption></figure></section><section id="Sec8"><h3 class="pmc_sec_title">Compound 89 regulated microtubular organization by inhibiting PI3K/Akt signaling</h3>
<p id="Par18">As a classical signaling cascade involved in the migration and invasion of cancer cells, the PI3K/Akt pathway had been reported to participate in the stabilization of microtubules [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Therefore, whether the influence of <strong>89</strong> on microtubule is also related to the regulation of PI3K/Akt signaling was further inspected. Immunoblotting analysis was used to measure the total and phosphorylated levels of PI3K and Akt proteins in HeLa, HCT116, and 4T1 cells. The results showed significant reduction in the expressions of p-PI3K and p-Akt upon treatment of <strong>89</strong>, while the overall levels of PI3K and Akt remained unchanged (Fig. <a href="#Fig6" class="usa-link">6A</a>). In addition, immunofluorescence experiment also confirmed the downregulation of <strong>89</strong> on the p-Akt expression in HeLa and HCT116 cells (Fig. <a href="#Fig6" class="usa-link">6B</a>). Meanwhile, recilisib as an activator of PI3K signaling was thus applied to validate the influence of <strong>89</strong> on microtubules. As revealed by Fig. <a href="#Fig6" class="usa-link">6C</a> from immunofluorescence analysis, the impaired microtubule network by <strong>89</strong> could be well recovered by further administration of recilisib in HeLa cells. In addition, the downregulated protein expression of α-tubulin and β-tubulin by <strong>89</strong> could also be reversed by treatment of recilisib according to Western blotting assay (Fig. <a href="#Fig6" class="usa-link">6D</a>). Collectively, these results demonstrated that <strong>89</strong> could disturb the microtubule network by inhibiting PI3K/Akt pathway.</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6. Compound 89 regulated microtubule stability via inhibiting PI3K/Akt signaling pathway.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365163_41420_2025_2679_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b55a/12365163/7d3efd55f906/41420_2025_2679_Fig6_HTML.jpg" loading="lazy" id="d33e964" height="999" width="767" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> HeLa, HCT116 and 4T1 cells were treated with indicated concentrations of <strong>89</strong>, and the expressions of key proteins of PI3K/Akt signaling were detected by Western immunoblotting assay with the indicated antibodies. <strong>B</strong> HeLa and HCT116 cells were treated with increasing concentrations of <strong>89</strong> for 24 h, and cells were stained for p-Akt (red) and the nucleus (blue) was stained with DAPI by immunofluorescence assay. <strong>C</strong> HeLa cells were pretreated with <strong>89</strong> (1.2 μM) for 12 h, then cells were treated with the PI3K activator recilisib (10 μM) for 12 h. Tubulin was stained with the anti-α-tubulin (green) and anti-β-tubulin (red) antibodies, while the nucleus (blue) was stained with DAPI by immunofluorescence assay. <strong>D</strong> HeLa cells were pretreated with <strong>89</strong> (1.2 μM) for 12 h, and then cells were treated recilisib (10 μM) for 12 h, and the expressions of α-tubulin and β-tubulin were detected by Western immunoblotting assay with the indicated antibodies.</p></figcaption></figure></section><section id="Sec9"><h3 class="pmc_sec_title">In vivo antitumor and target verification studies of 89</h3>
<p id="Par19">Subsequently, we utilized the orthotopic autologous transplantation mouse model described earlier to conduct an in vivo anti-tumor evaluation on <strong>89</strong> [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>], and the experimental animals were given intraperitoneal administration with 10 mg·kg<sup>−1</sup>
<strong>89</strong> or only PBS (control group) once every two days for 4 weeks. As shown in Fig. <a href="#Fig7" class="usa-link">7A–C</a>, treatment of <strong>89</strong> markedly suppressed the tumor growth and reduced the tumor volume. According to the immunohistochemical results, the Ki-67 and PCNA levels in the primary tumor tissues were markedly reduced in the <strong>89</strong>-treated group, indicating the inhibition of <strong>89</strong> against the tumor cell proliferation in vivo (Fig. <a href="#Fig7" class="usa-link">7D</a>). In addition, <strong>89</strong> also inhibited the metastasis of tumor from breast to lung (Fig. <a href="#Fig7" class="usa-link">7E, F</a>), in agreement with the findings from the in vitro assay. Meanwhile, observation under an ex vivo imaging system (Fig. <a href="#Fig7" class="usa-link">7G</a>) revealed that tumor cells grew aggressively and metastasized to remote organs in randomly selected mice of the control group but not in those of the <strong>89</strong>-treated group. Subsequently, the major organs of mice were excised and imaged to detect the tumor presence. The statistics in Fig. <a href="#Fig7" class="usa-link">7H</a> revealed that only two mice in the <strong>89-</strong>treated group exhibited obvious metastasis to the lung, with no further metastases observed. In comparison, the tumor progression in the untreated group was notably more aggressive, with all five mice developing severe metastasis, as evident in their lungs (<em>n</em> = 5), livers (<em>n</em> = 4), kidneys (<em>n</em> = 3) and spleens (<em>n</em> = 2). In addition, the α-tubulin and β-tubulin in tumor tissue from <strong>89</strong>-treated mice were also examined by immunohistofluorescence staining (Fig. <a href="#Fig7" class="usa-link">7I</a>), showing severely reduced and disturbed microtubule networks. Also, <strong>89</strong> suppressed the expression of α-tubulin and β-tubulin in the tumor according to Western blot analysis (Fig. <a href="#Fig7" class="usa-link">7J</a>), supporting its direct target in vivo as microtubule. Lastly, the reduced levels of p-PI3K and p-Akt in the tumor tissues from <strong>89</strong>-treated group corroborated the downregulation of <strong>89</strong> on PI3K/Akt signaling (Fig. <a href="#Fig7" class="usa-link">7K</a>), which suggested that the tumor growth and metastasis inhibitory effect of <strong>89</strong> also correlated with the suppression of this pathway in vivo.</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7. Compound 89 inhibited tumor growth and metastasis in vivo.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365163_41420_2025_2679_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b55a/12365163/2f1cfe04c409/41420_2025_2679_Fig7_HTML.jpg" loading="lazy" id="d33e1128" height="997" width="728" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> Representative images of the primary tumors removed from mice after administration of <strong>89</strong> (10 mg kg<sup>−1</sup>) or PBS once every 2 days for 28 day. <strong>B</strong> Primary tumor volume was measured each week (**<em>p</em> &lt; 0.01). <strong>C</strong> Primary tumor weight in each group was measured (**<em>p</em> &lt; 0.01). <strong>D</strong> Primary tumors were fixed and paraffin embedded. Five-micrometer (5 μm) sections were analyzed by IHC staining using anti-Ki-67 and anti-PCNA antibodies. Scale bar, 100 μm. <strong>E</strong>, <strong>F</strong> Metastatic lung nodules were visualized and then counted manually, and the differences were evaluated with Student <em>t</em> test (**<em>p</em> &lt; 0.01). <strong>G</strong> Ex vivo bioluminescence images were obtained for selected mice in each group to check the effect of <strong>89</strong> against distant metastasis. <strong>H</strong> The metastasis incidence to distant organs was quantified. <strong>I</strong> Primary tumor sections were stained for α-tubulin (green) and β-tubulin (green), and nuclei were counterstained with DAPI (blue). Scale bar, 100 μm. <strong>J</strong> Primary tumors were lysed and applied to immunoblotting analysis using α-tubulin and β-tubulin antibodies, with actin as a loading control. <strong>K</strong> Primary tumors were lysed and applied to immunoblotting analysis using the indicated antibodies, with actin as a loading control. Bars represent mean ± SD of three independent experiments. *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001 versus the control grou<em>p</em>.</p></figcaption></figure></section><section id="Sec10"><h3 class="pmc_sec_title">Compound 89 showed antitumor activity in human tumor organoids</h3>
<p id="Par20">The living cancer cells were separated from the patient breast tumor tissues via mechanical destruction followed by enzymatic digestion, and patient-derived organoids (PDOs) were successfully established, with the clinical details of the three patients (BC-PDO1, BC-PDO2, BC-PDO10) provided (Fig. <a href="#Fig8" class="usa-link">8A</a>). The acquired PDOs were treated with varying doses of <strong>89</strong> and they exhibited different responses to this drug administration. The results in Fig. <a href="#Fig8" class="usa-link">8A, B</a> revealed that the three PDOs were all sensitive to <strong>89</strong>, with IC<sub>50</sub> values of 1.07 (BC-PDO1), 0.81 (BC-PDO2) and 0.42 (BC-PDO10) μM, respectively. Subsequent investigations showed that <strong>89</strong> could decrease the cell viability of the PDOs and the effect was positively correlated with the concentrations (Fig. <a href="#Fig8" class="usa-link">8C</a>). Additionally, as the concentration of <strong>89</strong> increased, notable changes in the size and morphology of the PDOs were observed accordingly. As demonstrated in Fig. <a href="#Fig8" class="usa-link">8D</a>, the cell clusters within the three organoids decreased in size, the organoids became smaller, the cell mass broke down into individual cells, and eventually, some cells fragmented. Treatment with <strong>89</strong> also reduced the overall density of the PDOs (Fig. <a href="#Fig8" class="usa-link">8E</a>). These findings collectively indicated that compound <strong>89</strong> could act as a good lead molecule to be developed into more potential candidates for future antitumor studies.</p>
<figure class="fig xbox font-sm" id="Fig8"><h4 class="obj_head">Fig. 8. Compound 89 showed antitumor activity in human tumor organoids.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365163_41420_2025_2679_Fig8_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b55a/12365163/00a60dc727e7/41420_2025_2679_Fig8_HTML.jpg" loading="lazy" id="d33e1218" height="960" width="790" alt="Fig. 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> Patients’ basic information of the established PDOs and the responses to <strong>89</strong>. <strong>B</strong> The established PDOs were treated with increasing concentrations of <strong>89</strong> for 24 h, and representative images of the morphology of the PDOs were shown (scale bar, 20 μm). <strong>C</strong> The line graphs showed the cell viability of the PDOs treated with different concentrations of <strong>89</strong>. <strong>D</strong> Bright-field microscopy images showed the changes in the size and status of the PDOs after treatment with different concentrations of <strong>89</strong> (scale bar, 10 μm). <strong>E</strong> Relative PDOs density in response to different concentrations of <strong>89</strong>. *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001.</p></figcaption></figure></section><section id="Sec11"><h3 class="pmc_sec_title">Compound 89 showed no systematic toxicity on mice</h3>
<p id="Par21">To assess its possible toxicity on animals, <strong>89</strong> (10 mg·kg<sup>−1</sup>) or PBS was administrated every other day to healthy BALB/c mice for 28 consecutive days. The mice’s body weight was measured every seven days and organ weight measured at the completion of the experiment. Excitingly, there was no observed loss in the weight of both body and major organs of the animals treated with <strong>89</strong> (Fig. <a href="#Fig9" class="usa-link">9A, B</a>). Additionally, histological analysis showed that, compared with the PBS group, compound <strong>89</strong> did not cause observable impairment to the main animal organs (liver, heart, lung, kidney and spleen, Fig. <a href="#Fig9" class="usa-link">9C</a>). Furthermore, the serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT, indicators of liver function) and blood urea nitrogen (BUN, indicator of both liver and kidney health) of the tested mice were all measured after the experiment. As illustrated in Fig. <a href="#Fig9" class="usa-link">9D</a>, compound <strong>89</strong> showed no significant impact on the levels of the three indicators. These data collectively suggested that treatment of <strong>89</strong> did not induce notable toxicity in the experimental animals.</p>
<figure class="fig xbox font-sm" id="Fig9"><h4 class="obj_head">Fig. 9. Compound 89 showed no systematic toxicity on mice.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365163_41420_2025_2679_Fig9_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b55a/12365163/91df44c9c431/41420_2025_2679_Fig9_HTML.jpg" loading="lazy" id="d33e1274" height="794" width="790" alt="Fig. 9"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig9/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> Compound <strong>89</strong> or PBS (control) were administered to normal BALB/c mice at 10 mg kg<sup>−1</sup> once every two days for 28 day, and the mice’s body weight was monitored once a week. Each treatment group consisted of five mice. <strong>B</strong> Major organs were removed and the weight was measured from the executed mice after the last drug treatment. <strong>C</strong> Major organs of randomly selected mice from different groups were stained with H&amp;E (scale bar 100 μm) and observed under an inverted microscope (IX-71, Olympus, Tokyo, Japan). <strong>D</strong> Blood samples were collected 24 h after the last treatment and the serum concentrations of ALT, AST and BUN were measured using Fuji DRI-CHEM 7000i (Fujifilm, Japan).</p></figcaption></figure></section></section><section id="Sec12"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par22">Over the past several decades, tubulin inhibitors, including microtubule-destabilizing and stabilizing molecules have been widely applied as chemotherapeutics for cancer prevention [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>, <a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. At present, U.S. FDA-approved tubulin inhibitors, including taxanes and vinca alkaloids, continue to be utilized in clinical settings to treat hematological malignancies and various solid tumors [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>, <a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. However, the challenges of adverse effects and drug resistance persist due to prolonged usage. Owing to the intrinsic advantage of these traditional chemotherapies, such as their broad antitumor spectrum, continuing efforts have been put into the research and development of new type of tubulin inhibitors to circumvent the aforementioned deficiencies. In this study, we excavated from a huge compound library containing 200,340 molecules, a new potent tubulin aggregation inhibitor (<strong>89</strong>). This molecule significantly disrupted the structure and network of microtubules and displayed promising tumor growth and metastasis inhibitory effects both in vitro and in vivo.</p>
<p id="Par23">Taxane, vinca, and colchicine binding sites are the three most extensively investigated target sites of microtubules [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Previous preclinical work suggested that the colchicine-site MTAs exerted promising therapeutic advantages compared with the taxane-site and vinca-site MTAs [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>], and their much simpler structures greatly facilitated the syntheses and further structural modification. Therefore, studies on colchicine-site inhibitors have garnered significant attention in recent years [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>, <a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. Currently, several candidate molecules that bind to the colchicine site, including ABT-751 and CA-4P, are undergoing clinical practice for cancer treatment [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. However, they have not been approved by the FDA because of side effects [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Therefore, the development of more colchicine-site MTAs with improved efficacy and reduced toxicity is still of great importance. In the present work, a virtual screening based on the taxane and colchicine sites for new MTAs identified <strong>89</strong>, a nicotinic acid derived synthetic compound, as a promising hit molecule. Further EBI competitive assay and molecular docking analysis demonstrated that <strong>89</strong> bound tightly to the colchicine site at the interface of two tubulin protein subunits.</p>
<p id="Par24">As above discussed, known MTAs of the colchicine site, from the point of further drug development, incorporate obvious structural advantages compared with inhibitors of other binding sites, while excitingly compound <strong>89</strong> bears even better structural features than most previous colchicine-site inhibitors [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>, <a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. Firstly, <strong>89</strong> does not possess so many electron donating groups (<em>e.g</em>., OH and OMe) like the former ones do, which brings it structural stability. Secondly, the nearly “bald” framework (including the pyridine, piperidine, piperazine and benzene rings) of <strong>89</strong> leaves enough space for further structural optimizations. Thirdly, the nicotinic acid moiety, as the core structure of <strong>89</strong>, widely exists as a natural compound especially in animals, and it may endow <strong>89</strong> with good biocompatibility and thus decent pharmacokinetic profile. Collectively, these structural properties make <strong>89</strong> an ideal lead molecule for further structural modification and optimization.</p>
<p id="Par25">In conclusion, a novel tubulin inhibitor (<strong>89</strong>) has been identified from a commercially available compound library <em>via</em> virtual screening in the present study. Experimental investigations demonstrated that compound <strong>89</strong> efficiently suppressed the growth, blocked the migration, and induced the apoptosis and G<sub>2</sub>/M phase arrest of different tumor cells. In addition, it also suppressed the tumor growth and metastasis in vivo in mice and exerted promising antitumor capability in PDOs. Mechanistical studies validated that compound <strong>89</strong> functioned as a colchicine-site tubulin polymerization inhibitor and disrupted the dynamic equilibrium of tubulin assembly by inhibiting the PI3K/Akt pathway. To summarize, the present research has identified a novel template molecule that can be utilized in the development of next-generation MTAs for cancer treatment.</p></section><section id="Sec13"><h2 class="pmc_sec_title">Material and methods</h2>
<section id="Sec14"><h3 class="pmc_sec_title">Source of compounds</h3>
<p id="Par26">The compounds used in this study were obtained from a commercially available Specs library (Zoetermeer, The Netherlands).</p></section><section id="Sec15"><h3 class="pmc_sec_title">Virtual screening for tubulin inhibitors</h3>
<p id="Par27">Molecular docking-based virtual screening was conducted using the Glide 5.5 program in the Maestro software package (Schrödinger LLC, New York, NY, 2015). Protein-ligand complexes of tubulin (PDB IDs: 4O2B and 5LXT) were prepared through the Protein Preparation Wizard panel. This preparation included hydrogen addition, charge assignment, and removal of water molecules not within proximity to the binding pocket, followed by restrained energy optimization. Binding sites were defined within a 15 Å radius surrounding the ligands (colchicine and discodermolide), and grid files were generated. Subsequently, compounds from the Specs library were docked into the defined grids using extra precision mode. The docking results were subjected to clustering analysis using Pipeline Pilot 7.5 software.</p></section><section id="Sec16"><h3 class="pmc_sec_title">Molecular docking of compound 89</h3>
<p id="Par28">Molecular docking analysis for compound <strong>89</strong> at the colchicine binding site followed the same procedures as described in the virtual screening protocol.</p></section><section id="Sec17"><h3 class="pmc_sec_title">Cell lines and reagents</h3>
<p id="Par29">Details regarding the cell lines and reagents are provided in the supplementary materials.</p></section><section id="Sec18"><h3 class="pmc_sec_title">Animal studies</h3>
<p id="Par30">BALB/c mice (6–8 weeks old) were acquired from the Institute of Laboratory Animal Science of the Chinese Academy of Medical Sciences (Beijing, China). All animal experiments adhered to the guidelines approved by Qingdao University’s Institutional Animal Care and Ethics Committee (QDU-AEC-2024075). For therapeutic evaluations, mice were divided into two groups (<em>n</em> = 5 per group). The experimental group received intraperitoneal injections of Compound <strong>89</strong> (10 mg·kg<sup>−</sup><sup>1</sup>) every 2 days, while the control group was injected with PBS. Body weights were monitored weekly, and major organs were harvested for histological examination on day 28. An additional toxicity assessment was conducted on healthy mice under identical conditions.</p></section><section id="Sec19"><h3 class="pmc_sec_title">Cell viability assay</h3>
<p id="Par31">Cell viability was evaluated using the MTS assay [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. HeLa, HCT116, and 4T1 cells were seeded in 96-well plates at a density of 5 × 10³ cells/well. After 24 h, cells were treated with varying concentrations of test compounds. Absorbance at 490 nm was recorded after 24 h. Each experiment was repeated three times in triplicate.</p></section><section id="Sec20"><h3 class="pmc_sec_title">Colony formation assay</h3>
<p id="Par32">HeLa, HCT116, and 4T1 cells were seeded in 6-well plates and treated with different concentrations of compound <strong>89</strong> after 12 h. Colonies were allowed to form over 1–2 weeks, with media refreshed every other day. Cells were fixed with 4% paraformaldehyde, stained with 0.1% crystal violet, and manually counted.</p></section><section id="Sec21"><h3 class="pmc_sec_title">Soft agar colony formation assay</h3>
<p id="Par33">Soft agar assay involved the preparation of 1.2% and 0.7% agar, mixed with equal volumes of cell culture medium supplemented with FBS and antibiotics. A 1.2% agar layer was solidified in 6-well plates, then treated tumor cells were mixed into the 0.7% agar layer and overlaid. Cells were cultured for 14 days, supplemented with medium every 3 days, stained with crystal violet, and visualized under a microscope (Olympus BX53, Tokyo, Japan).</p></section><section id="Sec22"><h3 class="pmc_sec_title">Cell cycle analysis</h3>
<p id="Par34">HeLa and HCT116 cells were treated with compound <strong>89</strong>, fixed in 70% ethanol, and stored at 4 °C for 24 h. Cells were stained with RNase and propidium iodide (PI) solution, incubated at 37 °C for 30 min, and analyzed using flow cytometry.</p></section><section id="Sec23"><h3 class="pmc_sec_title">Apoptosis analysis</h3>
<p id="Par35">Apoptosis was assessed via Annexin V-FITC/PI staining. HeLa, HCT116, and 4T1 cells were treated with increasing concentrations of compound <strong>89</strong>, stained using an apoptosis detection kit, and analyzed using flow cytometry.</p></section><section id="Sec24"><h3 class="pmc_sec_title">Wound healing assay</h3>
<p id="Par36">A scratch was created on confluent monolayers of HeLa, HCT116, and 4T1 cells. Cells were treated with compound <strong>89</strong> in serum-free medium, and migration was evaluated after 24 h by imaging the wound closure.</p></section><section id="Sec25"><h3 class="pmc_sec_title">Cell invasion assay</h3>
<p id="Par37">Invasion assays were performed using Matrigel-coated transwell chambers. Serum-starved HeLa, HCT116, and 4T1 cells were placed in the upper chamber, and compound <strong>89</strong> was added to both compartments. After 12 h, invaded cells were stained and counted.</p></section><section id="Sec26"><h3 class="pmc_sec_title">Western blotting</h3>
<p id="Par38">Western blotting assay was performed as described previously [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. Briefly, cell lysates were prepared in RIPA buffer, and protein concentrations were measured using a BCA assay. Proteins were resolved via SDS-PAGE, transferred to PVDF membranes, blocked with BSA, and probed with specific primary and secondary antibodies. Signals were visualized using ECL reagents.</p></section><section id="Sec27"><h3 class="pmc_sec_title">Cellular thermal shift assay (CETSA)</h3>
<p id="Par39">Interaction between compound <strong>89</strong> and β-tubulin in living cells was analyzed by CETSA. HeLa cell lysates were treated with <strong>89</strong>, subjected to thermal denaturation, centrifuged, and the supernatant analyzed by Western blot.</p></section><section id="Sec28"><h3 class="pmc_sec_title">In vitro tubulin polymerization assay</h3>
<p id="Par40">The in vitro tubulin polymerization assay was performed according to the manufacturer’s instructions (Cytoskeleton, Cat# BK006P). Briefly, a series of concentrations of <strong>89</strong> (6.25, 12.5, 25, 50 and 100 μM), 10 μM paclitaxel, 10 μM colchicine and control (DMSO) were incubated with tubulin protein in 100 μL reaction buffer (pH 6.9) containing 80 mM piperazine-1,4-bisethanesulfonic acid, 2.0 mM MgCl<sub>2</sub>, 0.5 mM ethylene glycol tetraacetic acid, 15% glycerol, 1 mM guanosine-5′-triphosphate. The mixture was incubated at 37 °C in a microplate reader (Tecan Spark 10 M, Tecan, Austria) and the absorbance at 340 nm was recorded every 60 s for 1 h. Colchicine and paclitaxel were used as reference compounds.</p></section><section id="Sec29"><h3 class="pmc_sec_title">N,N’-Ethylenebis (EBI) competition assay</h3>
<p id="Par41">6-well plates were seeded with HeLa or HCT116 cells (2 × 10<sup>5</sup>) for 24 h, then the tumor cells were incubated with compound <strong>89</strong>, colchicine or DMSO for 2 h and afterward treated with EBI (100 μM) for 1.5 h. Finally, the cells were harvested and lysed, and the cell extracts were used for Western blotting analysis.</p></section><section id="Sec30"><h3 class="pmc_sec_title">Immunofluorescence staining</h3>
<p id="Par42">Cells were fixed, stained with primary and fluorescent secondary antibodies, and visualized using a fluorescence microscope.</p></section><section id="Sec31"><h3 class="pmc_sec_title">Histological and immunohistochemical (IHC) analysis</h3>
<p id="Par43">Histological and immunohistochemical analysis were performed as described previously [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. In brief, major organs and tumor tissues were fixed, paraffin-embedded, and sectioned for H&amp;E and IHC staining using antibodies against PCNA and Ki-67.</p></section><section id="Sec32"><h3 class="pmc_sec_title">Patient-derived organoid culture</h3>
<p id="Par44">Patients were informed before the surgery and agreed by written consent to donate tissues. All experiments were performed in accordance with the IRB committee’s regulations of Qingdao University on human subject research. All procedures were performed at the Affiliated Hospital of Qingdao University (QDU-HEC-2024044). The tissue was digested in 1 mL Dispase (Corning, diluted 1:5 in HBSS) and 1 mL Trypsin-EDTA (Invitrogen, 0.25%), followed by mechanical dissociation and passing through a 100 μm cell strainer (Falcon). Then the cells were resuspended in 40 μL Cultrex Reduced Growth Factor Basement Membrane Extract (BME), Type 2 (R&amp;D Systems, Cat# 3533–010-02) and seeded into Matrigel in a well of a pre-warmed 24-well flat-bottom cell culture plate (Corning). Then, the cells were incubated for 20 min in a cell incubator (37 °C with 5% CO<sub>2</sub>) to solidify the Matrigel and were subsequently overlaid with 400 μL of complete human organ culture medium. Medium was changed every 4 days and organoids were passaged every 1–4 weeks. All organoid lines were tested negative by the MycoAlert mycoplasma detection kit (Cat# LT07-318, Lonza). PDOs were observed and photographed as required.</p></section><section id="Sec33"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par45">All experiments except the in vivo study were structured with control and experimental groups and repeated at least three times. Data were presented as mean ± SD of at least three independent experiments. The “<em>n</em>” represents the number of biological replicates as indicated in the figure legends. A Student’s <em>t</em> test was used to compare the data between two groups (<em>p</em> &lt; 0.05 was considered to show statistical significance) unless otherwise indicated.</p></section></section><section id="Sec34"><h2 class="pmc_sec_title">Supplementary information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12365163/bin/41420_2025_2679_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary information</a><sup> (385.9KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12365163/bin/41420_2025_2679_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Full and uncropped western blots</a><sup> (1.2MB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>This project was financially supported by the National Natural Science Foundation of China (No. 82073729), Science Foundation of Qingdao Municipality (No. 24-4-4-zrjj-149-jch), Youth Innovation team of Shandong Province (2022KJ145). We thank for all members of our work team for helpful discussions.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Conceptualization, KZ, HZ; Methodology, PS, KLL, KZ, XJ, GZ; Investigation: PS, KLL, KZ, XJ, GZ; Formal analysis, PS, KLL, KZ, HZ, XJ, GZ; Data curation, PS, KZ, HZ, XJ, GZ; Writing (original draft), PS, KZ, HZ; Writing (review and editing), PS, HZ; Supervision, KZ, HZ; Project administration, HZ; Funding acquisition, HZ.</p></section><section id="notes2"><h2 class="pmc_sec_title">Data availability</h2>
<p>Data will be made available on request.</p></section><section id="FPar1"><h2 class="pmc_sec_title">Competing interests</h2>
<p id="Par46">The authors declare no competing interests.</p></section><section id="FPar2"><h2 class="pmc_sec_title">Ethics approval</h2>
<p id="Par47">All animal experiments were performed according to guidelines approved by the Institutional Animal Care and performed in accordance with the guidelines for Animal Experimentation of Qingdao University and approved by the Committee for Animal Experimentation (Approval No: QDU-AEC-2024075).</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1"><p><strong>Publisher’s note</strong> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div>
<div class="fn p" id="fn2"><p>These authors contributed equally: Peipei Shan, Kai-Lu Liu.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Peipei Shan, Email: shanpeipei@qdu.edu.cn.</p>
<p>Kongkai Zhu, Email: hkhhh.k@163.com.</p>
<p>Hua Zhang, Email: bio_zhangh@ujn.edu.cn.</p></section><section id="sec35"><h2 class="pmc_sec_title">Supplementary information</h2>
<p>The online version contains supplementary material available at 10.1038/s41420-025-02679-3.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer. 2004;4:253–65. 10.1038/nrc1317.
</cite> [<a href="https://doi.org/10.1038/nrc1317" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15057285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jordan%20MA,%20Wilson%20L.%20Microtubules%20as%20a%20target%20for%20anticancer%20drugs.%20Nat%20Rev%20Cancer.%202004;4:253%E2%80%9365.%2010.1038/nrc1317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Steinmetz MO, Prota AE. Microtubule-targeting agents: strategies to hijack the cytoskeleton. Trends Cell Biol. 2018;28:776–92. 10.1016/j.tcb.2018.05.001.
</cite> [<a href="https://doi.org/10.1016/j.tcb.2018.05.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29871823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Steinmetz%20MO,%20Prota%20AE.%20Microtubule-targeting%20agents:%20strategies%20to%20hijack%20the%20cytoskeleton.%20Trends%20Cell%20Biol.%202018;28:776%E2%80%9392.%2010.1016/j.tcb.2018.05.001." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Vicente JJ, Wordeman L. The quantification and regulation of microtubule dynamics in the mitotic spindle. Curr Opin Cell Biol. 2019;60:36–43. 10.1016/j.ceb.2019.03.017.
</cite> [<a href="https://doi.org/10.1016/j.ceb.2019.03.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6756986/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31108428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vicente%20JJ,%20Wordeman%20L.%20The%20quantification%20and%20regulation%20of%20microtubule%20dynamics%20in%20the%20mitotic%20spindle.%20Curr%20Opin%20Cell%20Biol.%202019;60:36%E2%80%9343.%2010.1016/j.ceb.2019.03.017." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Kueh HY, Mitchison TJ. Structural plasticity in actin and tubulin polymer dynamics. Science. 2009;325:960–3. 10.1126/science.1168823.
</cite> [<a href="https://doi.org/10.1126/science.1168823" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2864651/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19696342/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kueh%20HY,%20Mitchison%20TJ.%20Structural%20plasticity%20in%20actin%20and%20tubulin%20polymer%20dynamics.%20Science.%202009;325:960%E2%80%933.%2010.1126/science.1168823." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Nogales E. Structural insights into microtubule function. Annu Rev Biochem. 2000;69:277–302. 10.1146/annurev.biochem.69.1.277.
</cite> [<a href="https://doi.org/10.1146/annurev.biochem.69.1.277" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10966460/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nogales%20E.%20Structural%20insights%20into%20microtubule%20function.%20Annu%20Rev%20Biochem.%202000;69:277%E2%80%93302.%2010.1146/annurev.biochem.69.1.277." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Chang LC, Yu YL, Liu CY, Cheng YY, Chou RH, Hsieh MT, et al. The newly synthesized 2-arylnaphthyridin-4-one, CSC-3436, induces apoptosis of non-small cell lung cancer cells by inhibiting tubulin dynamics and activating CDK1. Cancer Chemother Pharmacol. 2015;75:1303–15. 10.1007/s00280-015-2765-0.
</cite> [<a href="https://doi.org/10.1007/s00280-015-2765-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25947085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chang%20LC,%20Yu%20YL,%20Liu%20CY,%20Cheng%20YY,%20Chou%20RH,%20Hsieh%20MT,%20et%20al.%20The%20newly%20synthesized%202-arylnaphthyridin-4-one,%20CSC-3436,%20induces%20apoptosis%20of%20non-small%20cell%20lung%20cancer%20cells%20by%20inhibiting%20tubulin%20dynamics%20and%20activating%20CDK1.%20Cancer%20Chemother%20Pharmacol.%202015;75:1303%E2%80%9315.%2010.1007/s00280-015-2765-0." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Foley EA, Kapoor TM. Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore. Nat Rev Mol Cell Bio. 2013;14:25–37. 10.1038/nrm3494.
</cite> [<a href="https://doi.org/10.1038/nrm3494" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3762224/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23258294/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Foley%20EA,%20Kapoor%20TM.%20Microtubule%20attachment%20and%20spindle%20assembly%20checkpoint%20signalling%20at%20the%20kinetochore.%20Nat%20Rev%20Mol%20Cell%20Bio.%202013;14:25%E2%80%9337.%2010.1038/nrm3494." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Zhao Y, Mu X, Du GH. Microtubule-stabilizing agents: new drug discovery and cancer therapy. Pharmacol Ther. 2016;162:134–43. 10.1016/j.pharmthera.2015.12.006.
</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2015.12.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26706241/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20Y,%20Mu%20X,%20Du%20GH.%20Microtubule-stabilizing%20agents:%20new%20drug%20discovery%20and%20cancer%20therapy.%20Pharmacol%20Ther.%202016;162:134%E2%80%9343.%2010.1016/j.pharmthera.2015.12.006." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Li YY, Yang JZ, Niu L, Hu DJ, Li HJ, Chen LJ, et al. Structural insights into the design of indole derivatives as tubulin polymerization inhibitors. FEBS Lett. 2020;594:199–204. 10.1002/1873-3468.13566.
</cite> [<a href="https://doi.org/10.1002/1873-3468.13566" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31369682/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20YY,%20Yang%20JZ,%20Niu%20L,%20Hu%20DJ,%20Li%20HJ,%20Chen%20LJ,%20et%20al.%20Structural%20insights%20into%20the%20design%20of%20indole%20derivatives%20as%20tubulin%20polymerization%20inhibitors.%20FEBS%20Lett.%202020;594:199%E2%80%93204.%2010.1002/1873-3468.13566." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Yan XY, Leng JF, Chen TT, Zhao YJ, Kong LY, Yin Y. Design, synthesis, and biological evaluation of novel diphenylamine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site. Eur J Med Chem. 2022;237:114372. 10.1016/j.ejmech.2022.114372.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2022.114372" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35447432/" class="usa-link">PubMed</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Sun YX, Song J, Kong LJ, Sha BB, Tian XY, Liu XJ, et al. Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities. Eur J Med Chem. 2022;229:114069. 10.1016/j.ejmech.2021.114069.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2021.114069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34971875/" class="usa-link">PubMed</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Arnst KE, Banerjee S, Chen H, Deng SS, Hwang DJ, Li W, et al. Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy. Med Res Rev. 2019;39:1398–426. 10.1002/med.21568.
</cite> [<a href="https://doi.org/10.1002/med.21568" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6857175/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30746734/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Arnst%20KE,%20Banerjee%20S,%20Chen%20H,%20Deng%20SS,%20Hwang%20DJ,%20Li%20W,%20et%20al.%20Current%20advances%20of%20tubulin%20inhibitors%20as%20dual%20acting%20small%20molecules%20for%20cancer%20therapy.%20Med%20Res%20Rev.%202019;39:1398%E2%80%93426.%2010.1002/med.21568." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>van Vuuren RJ, Visagie MH, Theron AE, Joubert AM. Antimitotic drugs in the treatment of cancer. Cancer Chemother Pharmacol. 2015;76:1101–12. 10.1007/s00280-015-2903-8.
</cite> [<a href="https://doi.org/10.1007/s00280-015-2903-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4648954/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26563258/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20Vuuren%20RJ,%20Visagie%20MH,%20Theron%20AE,%20Joubert%20AM.%20Antimitotic%20drugs%20in%20the%20treatment%20of%20cancer.%20Cancer%20Chemother%20Pharmacol.%202015;76:1101%E2%80%9312.%2010.1007/s00280-015-2903-8." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Ghawanmeh AA, Chong KF, Sarkar SM, Bakar MA, Othaman R, Khalid RM. Colchicine prodrugs and codrugs: chemistry and bioactivities. Eur J Med Chem. 2018;144:229–42. 10.1016/j.ejmech.2017.12.029.
</cite> [<a href="https://doi.org/10.1016/j.ejmech.2017.12.029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29274490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ghawanmeh%20AA,%20Chong%20KF,%20Sarkar%20SM,%20Bakar%20MA,%20Othaman%20R,%20Khalid%20RM.%20Colchicine%20prodrugs%20and%20codrugs:%20chemistry%20and%20bioactivities.%20Eur%20J%20Med%20Chem.%202018;144:229%E2%80%9342.%2010.1016/j.ejmech.2017.12.029." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Oluwalana D, Hartman K, Krutilina R, Chen H, Playa H, Deng SS, et al. A novel stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor targeting microtubules (60c) is effective against taxane-resistant, metastatic breast cancer. Cancer Res. 2024;84. 10.1158/1538-7445.Sabcs23-Po3-06-13.</cite>
</li>
<li id="CR16">
<span class="label">16.</span><cite>Borisy G, Heald R, Howard J, Janke C, Musacchio A, Nogales E. Microtubules: 50 years on from the discovery of tubulin. Nat Rev Mol Cell Biol. 2016;17:322–8. 10.1038/nrm.2016.45.
</cite> [<a href="https://doi.org/10.1038/nrm.2016.45" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5116387/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27103327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Borisy%20G,%20Heald%20R,%20Howard%20J,%20Janke%20C,%20Musacchio%20A,%20Nogales%20E.%20Microtubules:%2050%20years%20on%20from%20the%20discovery%20of%20tubulin.%20Nat%20Rev%20Mol%20Cell%20Biol.%202016;17:322%E2%80%938.%2010.1038/nrm.2016.45." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Kavallaris M. Microtubules and resistance to tubulin-binding agents. Nat Rev Cancer. 2010;10:194–204. 10.1038/nrc2803.
</cite> [<a href="https://doi.org/10.1038/nrc2803" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20147901/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kavallaris%20M.%20Microtubules%20and%20resistance%20to%20tubulin-binding%20agents.%20Nat%20Rev%20Cancer.%202010;10:194%E2%80%93204.%2010.1038/nrc2803." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Novais P, Silva PMA, Amorim I, Bousbaa H. Second-generation antimitotics in cancer clinical trials. Pharmaceutics. 2021;13:1011. 10.3390/pharmaceutics13071011.</cite> [<a href="https://doi.org/10.3390/pharmaceutics13071011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8309102/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34371703/" class="usa-link">PubMed</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Lu Y, Chen J, Xiao M, Li W, Miller DD. An overview of tubulin inhibitors that interact with the colchicine binding site. Pharm Res. 2012;29:2943–71. 10.1007/s11095-012-0828-z.
</cite> [<a href="https://doi.org/10.1007/s11095-012-0828-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3667160/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22814904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lu%20Y,%20Chen%20J,%20Xiao%20M,%20Li%20W,%20Miller%20DD.%20An%20overview%20of%20tubulin%20inhibitors%20that%20interact%20with%20the%20colchicine%20binding%20site.%20Pharm%20Res.%202012;29:2943%E2%80%9371.%2010.1007/s11095-012-0828-z." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Perez EA. Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol Cancer Ther. 2009;8:2086–95. 10.1158/1535-7163.MCT-09-0366.
</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-09-0366" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19671735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Perez%20EA.%20Microtubule%20inhibitors:%20differentiating%20tubulin-inhibiting%20agents%20based%20on%20mechanisms%20of%20action,%20clinical%20activity,%20and%20resistance.%20Mol%20Cancer%20Ther.%202009;8:2086%E2%80%9395.%2010.1158/1535-7163.MCT-09-0366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Egharevba GO, Kamal A, Dosumu OO, Routhu S, Fadare OA, Oguntoye SO, et al. Synthesis and characterization of novel combretastatin analogues of 1,1-diaryl vinyl sulfones, with antiproliferative potential via in-silico and in-vitro studies. Sci Rep. 2022;12:1901. 10.1038/s41598-022-05958-6.
</cite> [<a href="https://doi.org/10.1038/s41598-022-05958-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8814031/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35115623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Egharevba%20GO,%20Kamal%20A,%20Dosumu%20OO,%20Routhu%20S,%20Fadare%20OA,%20Oguntoye%20SO,%20et%20al.%20Synthesis%20and%20characterization%20of%20novel%20combretastatin%20analogues%20of%201,1-diaryl%20vinyl%20sulfones,%20with%20antiproliferative%20potential%20via%20in-silico%20and%20in-vitro%20studies.%20Sci%20Rep.%202022;12:1901.%2010.1038/s41598-022-05958-6." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Cui H, Wang Q, Miller DD, Li W. The tubulin inhibitor VERU-111 in combination with vemurafenib provides an effective treatment of vemurafenib-resistant A375 melanoma. Front Pharmacol. 2021;12:637098. 10.3389/fphar.2021.637098.
</cite> [<a href="https://doi.org/10.3389/fphar.2021.637098" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8027488/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33841154/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cui%20H,%20Wang%20Q,%20Miller%20DD,%20Li%20W.%20The%20tubulin%20inhibitor%20VERU-111%20in%20combination%20with%20vemurafenib%20provides%20an%20effective%20treatment%20of%20vemurafenib-resistant%20A375%20melanoma.%20Front%20Pharmacol.%202021;12:637098.%2010.3389/fphar.2021.637098." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Cogle CR, Collins B, Turner D, Pettiford LC, Bosse R, Hawkins KE, et al. Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes. Br J Haematol. 2020;189:e211–e213. 10.1111/bjh.16629.
</cite> [<a href="https://doi.org/10.1111/bjh.16629" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32236943/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cogle%20CR,%20Collins%20B,%20Turner%20D,%20Pettiford%20LC,%20Bosse%20R,%20Hawkins%20KE,%20et%20al.%20Safety,%20feasibility%20and%20preliminary%20efficacy%20of%20single%20agent%20combretastatin%20A1%20diphosphate%20(OXi4503)%20in%20patients%20with%20relapsed%20or%20refractory%20acute%20myeloid%20leukemia%20or%20myelodysplastic%20syndromes.%20Br%20J%20Haematol.%202020;189:e211%E2%80%93e213.%2010.1111/bjh.16629." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Shan P, Ye T, Tang YD, Song H, Wang C, Zhu K, et al. First total synthesis, antitumor evaluation and target identification of mornaphthoate E: a new tubulin inhibitor template acting on PI3K/Akt signaling pathway. Acta Pharm Sin B. 2024;14:2177–93. 10.1016/j.apsb.2024.02.012.
</cite> [<a href="https://doi.org/10.1016/j.apsb.2024.02.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11120283/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38799630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shan%20P,%20Ye%20T,%20Tang%20YD,%20Song%20H,%20Wang%20C,%20Zhu%20K,%20et%20al.%20First%20total%20synthesis,%20antitumor%20evaluation%20and%20target%20identification%20of%20mornaphthoate%20E:%20a%20new%20tubulin%20inhibitor%20template%20acting%20on%20PI3K/Akt%20signaling%20pathway.%20Acta%20Pharm%20Sin%20B.%202024;14:2177%E2%80%9393.%2010.1016/j.apsb.2024.02.012." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Steinmetz MO, Prota AE. Structure-based discovery and rational design of microtubule-targeting agents. Curr Opin Struct Biol. 2024;87:102845. 10.1016/j.sbi.2024.102845.
</cite> [<a href="https://doi.org/10.1016/j.sbi.2024.102845" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38805950/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Steinmetz%20MO,%20Prota%20AE.%20Structure-based%20discovery%20and%20rational%20design%20of%20microtubule-targeting%20agents.%20Curr%20Opin%20Struct%20Biol.%202024;87:102845.%2010.1016/j.sbi.2024.102845." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Yang J, Yu Y, Li Y, Yan W, Ye H, Niu L, et al. Cevipabulin-tubulin complex reveals a novel agent binding site on alpha-tubulin with tubulin degradation effect. Sci Adv. 2021;7:eabg4168. 10.1126/sciadv.abg4168.</cite> [<a href="https://doi.org/10.1126/sciadv.abg4168" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8133757/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34138737/" class="usa-link">PubMed</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Shuai W, Wang G, Zhang Y, Bu F, Zhang S, Miller DD, et al. Recent progress on tubulin inhibitors with dual targeting capabilities for cancer therapy. J Med Chem. 2021;64:7963–90. 10.1021/acs.jmedchem.1c00100.
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.1c00100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34101463/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shuai%20W,%20Wang%20G,%20Zhang%20Y,%20Bu%20F,%20Zhang%20S,%20Miller%20DD,%20et%20al.%20Recent%20progress%20on%20tubulin%20inhibitors%20with%20dual%20targeting%20capabilities%20for%20cancer%20therapy.%20J%20Med%20Chem.%202021;64:7963%E2%80%9390.%2010.1021/acs.jmedchem.1c00100." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004;47:1739–49. 10.1021/jm0306430.
</cite> [<a href="https://doi.org/10.1021/jm0306430" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15027865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Friesner%20RA,%20Banks%20JL,%20Murphy%20RB,%20Halgren%20TA,%20Klicic%20JJ,%20Mainz%20DT,%20et%20al.%20Glide:%20a%20new%20approach%20for%20rapid,%20accurate%20docking%20and%20scoring.%201.%20Method%20and%20assessment%20of%20docking%20accuracy.%20J%20Med%20Chem.%202004;47:1739%E2%80%9349.%2010.1021/jm0306430." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 2004;118:277–9. 10.1016/j.cell.2004.07.011.
</cite> [<a href="https://doi.org/10.1016/j.cell.2004.07.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15294153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kang%20Y,%20Massague%20J.%20Epithelial-mesenchymal%20transitions:%20twist%20in%20development%20and%20metastasis.%20Cell.%202004;118:277%E2%80%939.%2010.1016/j.cell.2004.07.011." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Onishi K, Higuchi M, Asakura T, Masuyama N, Gotoh Y. The PI3K-Akt pathway promotes microtubule stabilization in migrating fibroblasts. Genes Cells. 2007;12:535–46. 10.1111/j.1365-2443.2007.01071.x.
</cite> [<a href="https://doi.org/10.1111/j.1365-2443.2007.01071.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17397400/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Onishi%20K,%20Higuchi%20M,%20Asakura%20T,%20Masuyama%20N,%20Gotoh%20Y.%20The%20PI3K-Akt%20pathway%20promotes%20microtubule%20stabilization%20in%20migrating%20fibroblasts.%20Genes%20Cells.%202007;12:535%E2%80%9346.%2010.1111/j.1365-2443.2007.01071.x." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Shan P, Yang F, Qi H, Hu Y, Zhu S, Sun Z, et al. Alteration of MDM2 by the small molecule YF438 exerts antitumor effects in triple-negative breast cancer. Cancer Res. 2021;81:4027–40. 10.1158/0008-5472.CAN-20-0922.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-20-0922" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33985974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shan%20P,%20Yang%20F,%20Qi%20H,%20Hu%20Y,%20Zhu%20S,%20Sun%20Z,%20et%20al.%20Alteration%20of%20MDM2%20by%20the%20small%20molecule%20YF438%20exerts%20antitumor%20effects%20in%20triple-negative%20breast%20cancer.%20Cancer%20Res.%202021;81:4027%E2%80%9340.%2010.1158/0008-5472.CAN-20-0922." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Romagnoli R, Kimatrai Salvador M, Schiaffino Ortega S, Baraldi PG, Oliva P, Baraldi S, et al. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: design, synthesis, cell growth and tubulin polymerization inhibition. Eur J Med Chem. 2018;143:683–98. 10.1016/j.ejmech.2017.11.096.
</cite> [<a href="https://doi.org/10.1016/j.ejmech.2017.11.096" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5791907/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29220790/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Romagnoli%20R,%20Kimatrai%20Salvador%20M,%20Schiaffino%20Ortega%20S,%20Baraldi%20PG,%20Oliva%20P,%20Baraldi%20S,%20et%20al.%202-Alkoxycarbonyl-3-arylamino-5-substituted%20thiophenes%20as%20a%20novel%20class%20of%20antimicrotubule%20agents:%20design,%20synthesis,%20cell%20growth%20and%20tubulin%20polymerization%20inhibition.%20Eur%20J%20Med%20Chem.%202018;143:683%E2%80%9398.%2010.1016/j.ejmech.2017.11.096." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Li F, Liu Z, Sun H, Li C, Wang W, Ye L, et al. PCC0208017, a novel small-molecule inhibitor of MARK3/MARK4, suppresses glioma progression in vitro and in vivo. Acta Pharm Sin B. 2020;10:289–300. 10.1016/j.apsb.2019.09.004.
</cite> [<a href="https://doi.org/10.1016/j.apsb.2019.09.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7016295/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32082974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20F,%20Liu%20Z,%20Sun%20H,%20Li%20C,%20Wang%20W,%20Ye%20L,%20et%20al.%20PCC0208017,%20a%20novel%20small-molecule%20inhibitor%20of%20MARK3/MARK4,%20suppresses%20glioma%20progression%20in%20vitro%20and%20in%20vivo.%20Acta%20Pharm%20Sin%20B.%202020;10:289%E2%80%93300.%2010.1016/j.apsb.2019.09.004." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Dumontet C, Jordan MA. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov. 2010;9:790–803. 10.1038/nrd3253.
</cite> [<a href="https://doi.org/10.1038/nrd3253" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3194401/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20885410/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dumontet%20C,%20Jordan%20MA.%20Microtubule-binding%20agents:%20a%20dynamic%20field%20of%20cancer%20therapeutics.%20Nat%20Rev%20Drug%20Discov.%202010;9:790%E2%80%93803.%2010.1038/nrd3253." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Yang CH, Horwitz SB. Taxol((R)): the first microtubule stabilizing agent. Int J Mol Sci. 2017;18:1733. 10.3390/ijms18081733.</cite> [<a href="https://doi.org/10.3390/ijms18081733" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5578123/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28792473/" class="usa-link">PubMed</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Banerjee S, Arnst KE, Wang YX, Kumar G, Deng SS, Yang L, et al. Heterocyclic-fused pyrimidines as novel tubulin polymerization inhibitors targeting the colchicine binding site: structural basis and antitumor efficacy. J Med Chem. 2018;61:1704–18. 10.1021/acs.jmedchem.7b01858.
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.7b01858" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5912893/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29406710/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Banerjee%20S,%20Arnst%20KE,%20Wang%20YX,%20Kumar%20G,%20Deng%20SS,%20Yang%20L,%20et%20al.%20Heterocyclic-fused%20pyrimidines%20as%20novel%20tubulin%20polymerization%20inhibitors%20targeting%20the%20colchicine%20binding%20site:%20structural%20basis%20and%20antitumor%20efficacy.%20J%20Med%20Chem.%202018;61:1704%E2%80%9318.%2010.1021/acs.jmedchem.7b01858." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Li L, Jiang S, Li X, Liu Y, Su J, Chen J. Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site. Eur J Med Chem. 2018;151:482–94. 10.1016/j.ejmech.2018.04.011.
</cite> [<a href="https://doi.org/10.1016/j.ejmech.2018.04.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29649743/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20L,%20Jiang%20S,%20Li%20X,%20Liu%20Y,%20Su%20J,%20Chen%20J.%20Recent%20advances%20in%20trimethoxyphenyl%20(TMP)%20based%20tubulin%20inhibitors%20targeting%20the%20colchicine%20binding%20site.%20Eur%20J%20Med%20Chem.%202018;151:482%E2%80%9394.%2010.1016/j.ejmech.2018.04.011." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Weng H, Li J, Zhu H, Carver Wong KF, Zhu Z, Xu J. An update on the recent advances and discovery of novel tubulin colchicine binding inhibitors. Future Med Chem. 2023;15:73–95. 10.4155/fmc-2022-0212.
</cite> [<a href="https://doi.org/10.4155/fmc-2022-0212" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36756851/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Weng%20H,%20Li%20J,%20Zhu%20H,%20Carver%20Wong%20KF,%20Zhu%20Z,%20Xu%20J.%20An%20update%20on%20the%20recent%20advances%20and%20discovery%20of%20novel%20tubulin%20colchicine%20binding%20inhibitors.%20Future%20Med%20Chem.%202023;15:73%E2%80%9395.%2010.4155/fmc-2022-0212." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Hawash M. Recent advances of tubulin inhibitors targeting the colchicine binding site for cancer therapy. Biomolecules. 2022;12:1843. 10.3390/biom12121843</cite> [<a href="https://doi.org/10.3390/biom12121843" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9776383/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36551271/" class="usa-link">PubMed</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Rudek MA, Dasari A, Laheru D, He P, Jin R, Walker R, et al. Phase 1 study of ABT-751 in combination with CAPIRI (capecitabine and irinotecan) and bevacizumab in patients with advanced colorectal cancer. J Clin Pharmacol. 2016;56:966–73. 10.1002/jcph.681.
</cite> [<a href="https://doi.org/10.1002/jcph.681" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4892995/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26632033/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rudek%20MA,%20Dasari%20A,%20Laheru%20D,%20He%20P,%20Jin%20R,%20Walker%20R,%20et%20al.%20Phase%201%20study%20of%20ABT-751%20in%20combination%20with%20CAPIRI%20(capecitabine%20and%20irinotecan)%20and%20bevacizumab%20in%20patients%20with%20advanced%20colorectal%20cancer.%20J%20Clin%20Pharmacol.%202016;56:966%E2%80%9373.%2010.1002/jcph.681." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Grisham R, Ky B, Tewari KS, Chaplin DJ, Walker J. Clinical trial experience with CA4P anticancer therapy: focus on efficacy, cardiovascular adverse events, and hypertension management. Gynecol Oncol Res Pract. 2018;5:1. 10.1186/s40661-017-0058-5.
</cite> [<a href="https://doi.org/10.1186/s40661-017-0058-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5756341/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29318022/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Grisham%20R,%20Ky%20B,%20Tewari%20KS,%20Chaplin%20DJ,%20Walker%20J.%20Clinical%20trial%20experience%20with%20CA4P%20anticancer%20therapy:%20focus%20on%20efficacy,%20cardiovascular%20adverse%20events,%20and%20hypertension%20management.%20Gynecol%20Oncol%20Res%20Pract.%202018;5:1.%2010.1186/s40661-017-0058-5." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Ning N, Yu Y, Wu M, Zhang R, Zhang T, Zhu C, et al. A novel microtubule inhibitor overcomes multidrug resistance in tumors. Cancer Res. 2018;78:5949–57. 10.1158/0008-5472.CAN-18-0455.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-18-0455" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30135190/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ning%20N,%20Yu%20Y,%20Wu%20M,%20Zhang%20R,%20Zhang%20T,%20Zhu%20C,%20et%20al.%20A%20novel%20microtubule%20inhibitor%20overcomes%20multidrug%20resistance%20in%20tumors.%20Cancer%20Res.%202018;78:5949%E2%80%9357.%2010.1158/0008-5472.CAN-18-0455." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Yin H, Chen XT, Chi QN, Ma YN, Fu XY, Du SS, et al. The hybrid oncolytic peptide NTP-385 potently inhibits adherent cancer cells by targeting the nucleus. Acta Pharmacol Sin. 2023;44:201–10. 10.1038/s41401-022-00939-x.
</cite> [<a href="https://doi.org/10.1038/s41401-022-00939-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9813345/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35794372/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yin%20H,%20Chen%20XT,%20Chi%20QN,%20Ma%20YN,%20Fu%20XY,%20Du%20SS,%20et%20al.%20The%20hybrid%20oncolytic%20peptide%20NTP-385%20potently%20inhibits%20adherent%20cancer%20cells%20by%20targeting%20the%20nucleus.%20Acta%20Pharmacol%20Sin.%202023;44:201%E2%80%9310.%2010.1038/s41401-022-00939-x." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Yin H, Fu XY, Gao HY, Ma YN, Yao JF, Du SS, et al. Design, synthesis and anticancer evaluation of novel oncolytic peptide-chlorambucil conjugates. Bioorg Chem. 2023;138:106674. 10.1016/j.bioorg.2023.106674.
</cite> [<a href="https://doi.org/10.1016/j.bioorg.2023.106674" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37331169/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yin%20H,%20Fu%20XY,%20Gao%20HY,%20Ma%20YN,%20Yao%20JF,%20Du%20SS,%20et%20al.%20Design,%20synthesis%20and%20anticancer%20evaluation%20of%20novel%20oncolytic%20peptide-chlorambucil%20conjugates.%20Bioorg%20Chem.%202023;138:106674.%2010.1016/j.bioorg.2023.106674." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Ma Q, Jiang H, Ma L, Zhao G, Xu Q, Guo D, et al. The moonlighting function of glycolytic enzyme enolase-1 promotes choline phospholipid metabolism and tumor cell proliferation. Proc Natl Acad Sci USA. 2023;120:e2209435120. 10.1073/pnas.2209435120.
</cite> [<a href="https://doi.org/10.1073/pnas.2209435120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10104498/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37011206/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma%20Q,%20Jiang%20H,%20Ma%20L,%20Zhao%20G,%20Xu%20Q,%20Guo%20D,%20et%20al.%20The%20moonlighting%20function%20of%20glycolytic%20enzyme%20enolase-1%20promotes%20choline%20phospholipid%20metabolism%20and%20tumor%20cell%20proliferation.%20Proc%20Natl%20Acad%20Sci%20USA.%202023;120:e2209435120.%2010.1073/pnas.2209435120." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12365163/bin/41420_2025_2679_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary information</a><sup> (385.9KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12365163/bin/41420_2025_2679_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Full and uncropped western blots</a><sup> (1.2MB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data will be made available on request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cell Death Discovery are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41420-025-02679-3"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41420_2025_Article_2679.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (10.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12365163/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12365163/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12365163%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365163/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12365163/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12365163/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40830098/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12365163/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40830098/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12365163/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12365163/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="o3XVlosAtsV5WcpdWerhSyLU8PGNWIu28Mw7rGGriAiSemhXsnwQyjeSOkquGw2F">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
